CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-01 | Posard Matthew L. Director | Purchase | +10,000 | $4.45 | $44K | 50,000 |
| 2021-11-30 | Patel Sujal M CEO, President, and Secretary | Purchase | +161,978 | $4.72 | $765K | 9,776,366 |
| 2021-11-30 | Posard Matthew L. Director | Purchase | +20,000 | $4.57 | $91K | 20,000 |
| 2021-11-24 | Mowry Anna CFO and Treasurer | Purchase | +15,000 | $4.58 | $69K | 32,500 |
| 2021-11-15 | McIlwain Matthew S Director | Purchase | +100,000 | $5.30 | $530K | 459,075 |
| 2021-08-26 | McIlwain Matthew S Director | Purchase | +11,709 | $7.71 | $90K | 359,075 |
| 2021-08-25 | McIlwain Matthew S Director | Purchase | +11,693 | $7.74 | $90K | 347,366 |
| 2021-08-24 | McIlwain Matthew S Director | Purchase | +13,568 | $7.68 | $104K | 335,673 |
| 2021-08-13 | Murphy Matthew B. General Counsel | Purchase | +5,000 | $7.56 | $38K | 34,140 |
| 2021-08-12 | Mowry Anna CFO and Treasurer | Purchase | +17,500 | $7.71 | $135K | 17,500 |
| 2021-06-14 | Murphy Matthew B. General Counsel | Grant or award · Stock Option (Right to Buy) | +326,526 | 326,526 | ||
| 2021-06-09 | ALTMAN MICHAEL SETH Director | Conversion | +3,647,500 | 3,647,500 | ||
| 2021-06-09 | ALTMAN MICHAEL SETH Director | Conversion | −499,000 | 0 | ||
| 2021-06-09 | ALTMAN MICHAEL SETH Director | Conversion | +499,000 | 499,000 | ||
| 2021-06-09 | ALTMAN MICHAEL SETH Director | Conversion · Class B ordinary shares | −3,647,500 | 0 | ||
| 2021-06-09 | ALTMAN MICHAEL SETH Director | Grant or award · Stock Option (Right to buy) | +44,435 | 44,435 | ||
| 2021-06-09 | PERCEPTIVE ADVISORS LLC Former Director | Purchase | +5,500,000 | $10.00 | $55.0M | 5,997,038 |
| 2021-06-09 | PERCEPTIVE ADVISORS LLC Former Director | Other acquisition | +2,914,113 | 8,911,151 | ||
| 2021-06-03 | PERCEPTIVE ADVISORS LLC Director | Purchase | +330,050 | $10.05 | $3.3M | 489,975 |
| 2021-05-24 | PERCEPTIVE ADVISORS LLC Former Director | Purchase | +7,063 | $10.05 | $71K | 497,038 |
Page 7 of 8 · 144 trades